The New England Journal of Medicine

This is a special book for doctors. It shares new ways to help sick people. It started a long time ago. Doctors first made it in 1812.

It shares news about the body. It tells doctors about new tools. One tool helps people sleep during surgery. This is called an anesthetic.

Doctors also learn about the heart here. They read about how to make a heart beat again. This uses a small electric tool.

The book has a special picture. It shows a snake on a rod. It also shows a pen for writing.

Doctors read this book to stay smart. It helps them learn how to save lives.

The New England Journal of Medicine is a famous medical journal. It is published every week. It helps doctors learn about new ways to treat patients. The journal began in 1812. It started as a paper called the New England Journal of Medicine and Surgery. In 1928, it took its current name.

This journal shares many big discoveries. In 1846, it reported on a new way to help people sleep during surgery. This is called an anesthetic. It used a gas called ether. In 1952, it shared news about a tool that helps a heart beat. This tool is a pacemaker. It uses electricity to help the heart.

The journal also has a special rule. It is called the Ingelfinger rule. This rule says that researchers must not share their work anywhere else first. This helps make sure the work is checked by other experts. This checking is called peer review. Peer review helps keep the science true.

The journal has a logo. It shows a pen and a rod with a snake. The snake is on the Rod of Asclepius. This is an old symbol for medicine.

The New England Journal of Medicine is a very important weekly journal. It helps doctors around the world learn about new medical discoveries. It is published by the Massachusetts Medical Society. This journal is highly respected in the field of medicine. In 2024, it had an impact factor of 78.5. This number shows how much other journals use its work. It ranked 2nd out of 168 journals in the category of General and Internal Medicine.

How does the journal make sure its information is correct? It uses a process called peer review. This means other experts check the research before it is published. The journal also follows the Ingelfinger rule. This rule says researchers cannot share their work anywhere else first. This helps protect the newness of the discovery. It also ensures the work is checked by experts before the public sees it. This rule was first described in 1969 by an editor named Franz Ingelfinger.

The journal has a long and changing history. It began in January 1812. At first, it was called the New England Journal of Medicine and Surgery and Collateral Branches of Science. In 1823, a publication called the Boston Medical Intelligencer appeared. In 1828, the two were merged into the Boston Medical and Surgical Journal. This change moved the journal from quarterly to weekly publication. In 1921, the Massachusetts Medical Society bought the journal for one dollar. It finally took its current name in 1928.

Many famous medical moments were shared in these pages. In 1846, Henry Jacob Bigelow reported on the first use of ether as an anesthetic. This helped patients stay asleep during surgery. In 1948, Sidney Farber reported on treating childhood leukemia. In 1952, Paul Zoll shared a report on using an electric pacemaker to help a heart beat. In 1973, the journal published the first report on removing polyps with a colonoscope. These reports helped change how doctors treat people every day.

You can see the journal's history in its logo. The logo shows a quill pen crossed with the Rod of Asclepius. The Rod of Asclepius is a staff with a snake wrapped around it. This is an old symbol for medicine. The logo also includes four important dates. These dates are 1812, 1823, 1828, and 1928. Each date marks a step in how the journal was built. It connects the old history to the modern medical world.

The New England Journal of Medicine (NEJM) is a weekly medical journal. It is published by the Massachusetts Medical Society. This journal is one of the most prestigious publications for medical research. It is known for its high impact factor, which measures how often its articles are cited by other researchers. In 2024, the journal had an impact factor of 78.5. This score ranked it 2nd out of 168 journals in the "Medicine, General & Internal" category.

The journal follows a strict process to ensure research is accurate. This process is called peer review. Before an article is published, other experts in the same field examine the work. This helps verify that the findings are reliable. The journal also follows the Ingelfinger rule. This policy prevents researchers from releasing their findings elsewhere before they are published in the journal. This rule protects the news value of the research. It also ensures that experts can review the data before the public sees it. Franz Ingelfinger, a former editor-in-chief, first described this rule in a 1969 editorial.

The history of the NEJM involves several different publications merging over time. In September 1811, physician John Collins Warren and James Jackson proposed a new medical journal. The first issue was published in January 1812. It was originally called the New England Journal of Medicine and Surgery and Collateral Branches of Medical Science. At first, it was published only four times a year. In 1823, a different publication called the Boston Medical Intelligencer was founded. In 1828, the editors merged these two publications. They formed the Boston Medical and Surgical Journal and began publishing every week. In 1921, the Massachusetts Medical Society purchased the journal for one dollar. It officially took its current name in 1928.

The journal's logo tells the story of these historical changes. It features a quill pen crossed over the Rod of Asclepius. The Rod of Asclepius is a traditional symbol of medicine showing a snake wrapped around a staff. The logo includes four specific dates to honor the journal's components. The year 1812 marks the first journal. The year 1823 represents the Boston Medical Intelligencer. The year 1828 marks the merged Boston Medical and Surgical Journal. Finally, 1928 marks the adoption of the current name.

Many landmark medical discoveries have been published in the NEJM. In 1846, Henry Jacob Bigelow reported on the first public use of ether as a modern anesthetic. This allowed patients to remain unconscious during surgeries like amputations. In 1906, James Homer Wright described how to study bone marrow using stains. He identified structures now called platelets and megakaryocytes. In 1948, Sidney Farber published results on treating childhood leukemia. He used a substance called aminopterin to block folic acid metabolism. In 1952, Paul Zoll reported on using an artificial, external, electric pacemaker. This helped keep patients alive during heart emergencies.

The journal has also documented modern medical shifts and controversies. In 1973, it published the first report on using a colonoscope to remove polyps. This procedure helps reduce the risk of cancer. In 1981, the journal published two landmark articles about the disease that became known as AIDS. More recently, in 2001, Brian Druker reported on a targeted therapy for chronic myelogenous leukemia. This helped start a new era of designing drugs to target specific molecular problems. However, the journal has faced criticism. In the early 2000s, a controversy arose regarding research on the drug Vioxx. It was later discovered that some authors knew about certain heart risks before publication.

Today, the NEJM continues to evolve through digital technology. It began using the internet in 1996 to publish weekly abstracts and editorials. By 1998, the website included the full text of all articles from 1993 onward. The digital platform now includes educational videos and interactive medical cases. These cases allow readers to practice clinical encounters using patient histories and test results. In 2022, the society created a new sub-journal called NEJM Evidence. This monthly digital journal focuses specifically on clinical trials and medical decision-making. The journal remains a central part of the global medical system.